Solid-state digital gamma camera developer Digirad has received a $20 million cash infusion from a venture capital group. The San Diego-based vendor will use the equity financing to scale up manufacturing and build a sales and marketing infrastructure to
Solid-state digital gamma camera developer Digirad has received a $20 million cash infusion from a venture capital group. The San Diego-based vendor will use the equity financing to scale up manufacturing and build a sales and marketing infrastructure to support the launch of Digirad 2020 TC Imager, nuclear medicine's first solid-state digital camera cleared for marketing in the U.S. The venture capital group is led by Vector Fund Management, according to the company.
Digirad received Food and Drug Administration 510(k) clearance for 2020 TC Imager just days before the start of the Society of Nuclear Medicine meeting in San Diego (SCAN 6/11/97). The scanner, formerly known as Notebook Imager, is the company's first commercially available product.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.